28.01.2015 Views

Milk-and-Dairy-Products-in-Human-Nutrition-FAO

Milk-and-Dairy-Products-in-Human-Nutrition-FAO

Milk-and-Dairy-Products-in-Human-Nutrition-FAO

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

250<br />

<strong>Milk</strong> <strong>and</strong> dairy products <strong>in</strong> human nutrition<br />

Maximum permissible limits for antibiotic residues <strong>in</strong> foods are established<br />

to ensure prudent use of antimicrobials <strong>and</strong> safeguard public health. Excessive<br />

residues of antimicrobials <strong>in</strong> milk can also affect process<strong>in</strong>g because they may<br />

partially or completely <strong>in</strong>hibit acid production by starter cultures <strong>in</strong> cheese- <strong>and</strong><br />

yoghurt-mak<strong>in</strong>g, or <strong>in</strong>adequate ripen<strong>in</strong>g <strong>and</strong> age<strong>in</strong>g of cheese <strong>and</strong> resultant flavour/texture<br />

defects.<br />

Residues <strong>in</strong> milk can be m<strong>in</strong>imized by adher<strong>in</strong>g to good veter<strong>in</strong>ary <strong>and</strong> husb<strong>and</strong>ry<br />

practices. <strong>FAO</strong> <strong>and</strong> WHO (2009) sets out the overarch<strong>in</strong>g pr<strong>in</strong>ciples <strong>and</strong> guidance<br />

for governments on the design <strong>and</strong> implementation of national <strong>and</strong> trade-related<br />

food-safety-assurance programmes for residues of veter<strong>in</strong>ary drugs <strong>and</strong> provides<br />

guidel<strong>in</strong>es on best use of veter<strong>in</strong>ary drugs by food producers <strong>and</strong> processors.<br />

In practice, at the national level each registered antimicrobial preparation has a<br />

recommended withdrawal time before milk<strong>in</strong>g which must be adhered to <strong>in</strong> order to<br />

avoid excessive levels of residues <strong>in</strong> the milk (Fischer et al., 2003). Failure to adhere<br />

to withhold<strong>in</strong>g periods is the most commonly cited reason for drug residues <strong>in</strong><br />

marketed milk <strong>in</strong> temperate countries (Zwald et al., 2004). Other important reasons<br />

why residues occur at excessive levels <strong>in</strong>clude <strong>in</strong>correct route of adm<strong>in</strong>istration<br />

<strong>and</strong> dosage, use of antimicrobials not registered for dairy cows <strong>and</strong> <strong>in</strong>correct use<br />

without tak<strong>in</strong>g <strong>in</strong>to consideration lactation status.<br />

Antimicrobial resistance<br />

Antimicrobial drugs play a critical role <strong>in</strong> disease prevention, thus contribut<strong>in</strong>g to<br />

animal <strong>and</strong> human health. However, the misuse or <strong>in</strong>appropriate use of antimicrobials<br />

for treatment <strong>and</strong> prevention of diseases <strong>in</strong> food animals may lead to the emergence<br />

<strong>and</strong> spread of micro-organisms resistant to antimicrobials, lead<strong>in</strong>g to reduced<br />

effectiveness of antimicrobials <strong>in</strong> treat<strong>in</strong>g diseases <strong>in</strong> humans <strong>and</strong> animals. The<br />

risk appears to be greater <strong>in</strong> countries that have weak, <strong>in</strong>adequate or non-existent<br />

national policies, regulatory, surveillance <strong>and</strong> monitor<strong>in</strong>g systems for antimicrobial<br />

resistance <strong>and</strong> antimicrobial drug usage. To address this issue at the global level, the<br />

Codex Alimentarius Commission has adopted guidel<strong>in</strong>es for risk analysis of foodborne<br />

antimicrobial resistance (<strong>FAO</strong> <strong>and</strong> WHO, 2011a) <strong>and</strong> a code of practice to<br />

m<strong>in</strong>imize <strong>and</strong> conta<strong>in</strong> antimicrobial resistance (<strong>FAO</strong> <strong>and</strong> WHO, 2005).<br />

Antimicrobial resistance is not a great concern where milk is rout<strong>in</strong>ely pasteurized<br />

or receives equivalent process<strong>in</strong>g, because these <strong>in</strong>activate bacteria. However,<br />

it may be of concern where:<br />

• pasteurization is not m<strong>and</strong>atory or is m<strong>and</strong>atory for cow milk but not for<br />

milk from other species, e.g. sheep, goat or camel;<br />

• post-pasteurization or process<strong>in</strong>g contam<strong>in</strong>ation occurs (this is not common<br />

but does happen);<br />

• dairy products are made from unpasteurized milk or cream, particularly soft<br />

cheeses where process<strong>in</strong>g does not <strong>in</strong>active bacteria sufficiently; or<br />

• consumers prefer unpasteurized products.<br />

Growth promoters<br />

The growth promoter of most relevance to milk <strong>and</strong> dairy products is recomb<strong>in</strong>ant<br />

bov<strong>in</strong>e somatotrop<strong>in</strong> (rBST), a hormone used <strong>in</strong> some countries to <strong>in</strong>crease milk<br />

production <strong>in</strong> lactat<strong>in</strong>g bov<strong>in</strong>e cows (Khaniki, 2007). <strong>FAO</strong> <strong>and</strong> WHO (1998)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!